Skip to Content

Lepirudin

In the US, Lepirudin (lepirudin systemic) is a member of the drug class thrombin inhibitors and is used to treat Thrombocytopenia Drug Induced.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AE02

CAS registry number (Chemical Abstracts Service)

0138068-37-8

Chemical Formula

C287-H440-N80-O111-S6

Molecular Weight

6979

Therapeutic Categories

Anticoagulant agent: Direct thrombin inhibitor

Hirudin derivative

Chemical Name

1-L-Leucine-2-L-treonine-63-desulfohirudin (Hirudo medicinalisisoform HV1)

Foreign Names

  • Lepirudinum (Latin)
  • Lepirudin (German)
  • Lepirudine (French)
  • Lepirudina (Spanish)

Generic Names

  • Lepirudin (OS: BAN)
  • HBW 023 (IS: Chiron Behring)
  • rDNA-Hirudin (IS)

Brand Names

  • Refludan
    Celgene, Australia; Celgene, Ireland; Celgene, Lithuania; Celgene, Portugal; Hoechst, Greece
  • Refludin
    Celgene, Spain

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide